Get the Stockscreener App
23.56
1.09%
-0.26
ARK Genomic Revolution ETF stock is traded at $23.56, with a volume of 2.45M.
It is down -1.09% in the last 24 hours and down -2.52% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$23.82
Open:
$23.25
24h Volume:
2.45M
Relative Volume:
0.99
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-9.38%
1M Performance:
-2.52%
6M Performance:
-12.22%
1Y Performance:
-9.52%
1-Day Range:
$23.07
$23.82
1-Week Range:
$23.07
$26.29
52-Week Range:
$17.50
$31.16
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
23.56 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
305.74 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
621.72 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
624.65 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
237.58 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
553.88 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion - Benzinga
Unusually active option classes on open August 1st - TipRanks
ARKG Makes Notable Cross Below Critical Moving Average - Nasdaq
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium - MSN
Palantir, Nvidia & Tempus AI: The Future of Medicine in 2025 - AInvest
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills - inkl
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
TWST vs. NTRA: Which Genomics Play Is a Better Buy? - 24/7 Wall St.
ARKG: April's Wash-Out Low Is Encouraging, Healthcare Still Soft (BATS:ARKG) - Seeking Alpha
Why Cathie Wood Is Loading Up On This Hot Growth Stock (And Should You?) - Barchart.com
Cathie Wood Boosts ILMN and NVDA Stocks, Cuts RKLB Stake Again - AInvest
Learn to Evaluate (ARKG) using the Charts - news.stocktradersdaily.com
Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences - 富途牛牛
Cathie Wood Bets Over $17M on Crypto and AI Stocks, 7/17/2025 - TipRanks
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9… - inkl
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs - Benzinga
US stocks close mixed, but near the lows for the day - Forexlive | Forex News, Technical Analysis & Trading Tools
ROKU, ACHR: Cathie Wood Offloads Millions in Roku and Archer Aviation Stocks - TipRanks
BMO Announces Final Valuations and Declares Final Distributions on Units of ETF Series of Terminated BMO Mutual Funds - The Globe and Mail
Cathie Wood Invests $1M in Tempus AI, Sells Crypto Stocks Amid Bitcoin Rally - AInvest
Cathie Wood Bets Another $1 Million On Tempus AI… - inkl
Cathie Wood Bets Another $1 Million On Tempus AI Despite Jim Cramer's Doubts, Dumps Crypto Stocks As Bitcoin Hits Fresh New Highs - Benzinga
Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist' - inkl
Cathie Wood's ARK Loads Up on Tempus AI, Cuts Roku and Block - TradingView
Cathie Wood Makes Her Largest Trade of the Day in This AI Stock, 7/10/2025 - TipRanks
Cathie Wood Dumps Jack Dorsey's Block As Bitcoin Flirts With All-Time Highs, Bets $8.8 million On Tempus AI - Benzinga
Cathie Wood shells out $13.9 million for one high-stakes biotech stock - Yahoo Finance
Cathie Wood Marks Independence Day with Strategic Buys and a Major Sell-Off - TipRanks
15 ETFs That Have Destroyed the Most Wealth Over the Past Decade - Morningstar
Cathie Wood's ARK ETFs Gain 34% Year-to-Date Led by ARKW and ARKF - AInvest
Cathie Wood Is Dumpster Diving Again With These 3 Stock Buys - 24/7 Wall St.
Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet - Benzinga
(ARKG) Technical Data - news.stocktradersdaily.com
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? - Benzinga
Is eToro good for ETF investing in the UK? - Good Money Guide
Cathie Wood Comeback: These 2 Ark ETFs are Sailing Higher Again - 24/7 Wall St.
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It - Benzinga
Cathie Wood’s Ark Invest goes all in on AI stock - Crypto News
Amazon (AMZN) and AMD (AMD) Bought by ARK ETFs as Portfolio Rebalancing Continues - TradingView
Amazon (AMZN) and AMD (AMD) Bought by ARK ETFs as Portfolio Reba - GuruFocus
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration - Benzinga
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal - Benzinga
Captrust Financial Advisors Sells 2,012 Shares of ARK Genomic Revolution ETF (BATS:ARKG) - Defense World
ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Cetera Investment Advisers - Defense World
Long Term Trading Analysis for (ARKG) - news.stocktradersdaily.com
How many ARK funds are there: What are the 7 ARK ETFs? - Markets.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
Tracking Cathie Wood’s ARK Invest 13F Portfolio – Q1 2025 Update (BATS:ARKK) - Seeking Alpha
(ARKG) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Worst Thematic ETFs of 2021: How are they faring today? - Trackinsight
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.86%
Cap:
|
Volume (24h):